Trial NCT05431582

View at ClinicalTrials.gov 
Org. Study IDs: 2021-0175
Secondary IDs: NCI-2022-05251

Last trial update was posted on 2023-06-15

MeSH Interventions

Bevacizumab Pembrolizumab

MeSH Conditions


Other Conditions

Breast Cancer Lung Cancer Ovarian Cancer Pancreatic Cancer Tumors

Stopping Reasons

No participants enrolled

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID